Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yong Mi Choi-Sledeski

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Medicinal Chemistry|February 21, 2003
Molecular structures of human factor Xa complexed with ketopiperazine inhibitors: preference for a neutral group in the S1 pocketSébastien Maignan, Jean-Pierre Guilloteau, Yong Mi Choi-Sledeski, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2012
A β-tryptase inhibitor with a tropanylamide scaffold to improve in vitro stability and to lower hERG channel binding affinityGuyan Liang, Yong Mi Choi-Sledeski, Patrick Shum, et al.
Bioorganic & Medicinal Chemistry Letters|April 10, 2012
Dimerization of β-tryptase inhibitors, does it work for both basic and neutral P1 groups?Guyan Liang, Yong Mi Choi-Sledeski, Xin Chen, et al.
ACS Medicinal Chemistry Letters|October 16, 2020
Brain Penetrable Inhibitors of Ceramide Galactosyltransferase for the Treatment of Lysosomal Storage DisordersSukanthini Thurairatnam, Sungtaek Lim, Robert H Barker, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2010
A conformationally constrained inhibitor with an enhanced potency for β-tryptase and stability against semicarbazide-sensitive amine oxidase (SSAO)Guyan Liang, Yong Mi Choi-Sledeski, Gregory Poli, et al.
Bioorganic & Medicinal Chemistry Letters|July 14, 2024
Discovery of the first selective, small-molecule GFRα2/3 inhibitors through DNA-encoded library technologyShea L Johnson, Galen Missig, Minghua Wang, et al.
Journal of Medicinal Chemistry|February 21, 2003
Discovery of an orally efficacious inhibitor of coagulation factor Xa which incorporates a neutral P1 ligandYong Mi Choi-Sledeski, Robert Kearney, Gregory Poli, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Medicinal Chemistry|February 21, 2003
Molecular structures of human factor Xa complexed with ketopiperazine inhibitors: preference for a neutral group in the S1 pocketSébastien Maignan, Jean-Pierre Guilloteau, Yong Mi Choi-Sledeski, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2012
A β-tryptase inhibitor with a tropanylamide scaffold to improve in vitro stability and to lower hERG channel binding affinityGuyan Liang, Yong Mi Choi-Sledeski, Patrick Shum, et al.
Bioorganic & Medicinal Chemistry Letters|April 10, 2012
Dimerization of β-tryptase inhibitors, does it work for both basic and neutral P1 groups?Guyan Liang, Yong Mi Choi-Sledeski, Xin Chen, et al.
ACS Medicinal Chemistry Letters|October 16, 2020
Brain Penetrable Inhibitors of Ceramide Galactosyltransferase for the Treatment of Lysosomal Storage DisordersSukanthini Thurairatnam, Sungtaek Lim, Robert H Barker, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2010
A conformationally constrained inhibitor with an enhanced potency for β-tryptase and stability against semicarbazide-sensitive amine oxidase (SSAO)Guyan Liang, Yong Mi Choi-Sledeski, Gregory Poli, et al.
Bioorganic & Medicinal Chemistry Letters|July 14, 2024
Discovery of the first selective, small-molecule GFRα2/3 inhibitors through DNA-encoded library technologyShea L Johnson, Galen Missig, Minghua Wang, et al.
Journal of Medicinal Chemistry|February 21, 2003
Discovery of an orally efficacious inhibitor of coagulation factor Xa which incorporates a neutral P1 ligandYong Mi Choi-Sledeski, Robert Kearney, Gregory Poli, et al.
Pageof 1